Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder

•Early improvement of depressive symptoms predicted fewer cognitive disturbances.•This was particularly relevant to subjective residual symptoms of cognition.•Early response predicted objective cognition when performance is poor at baseline. Patients with major depressive disorder (MDD) frequently r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of affective disorders 2022-01, Vol.296, p.95-102
Hauptverfasser: Sumiyoshi, Tomiki, Hoshino, Tatsuya, Mishiro, Izumi, Hammer-Helmich, Lene, Ge, Holly, Moriguchi, Yoshiya, Fujikawa, Keita, Fernandez, Jovelle L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Early improvement of depressive symptoms predicted fewer cognitive disturbances.•This was particularly relevant to subjective residual symptoms of cognition.•Early response predicted objective cognition when performance is poor at baseline. Patients with major depressive disorder (MDD) frequently retain cognitive disturbances after recovery from mood symptoms. We investigated the relationship between early response of mood symptoms and/or remission, and residual cognitive disturbances after 6 months of antidepressant treatment. 518 patients with MDD were followed up for 6 months after antidepressant treatment initiation (first-line or switch from a previous drug). Subjective and objective cognitive disturbances were assessed by the Perceived Deficits Questionnaire – Depression (PDQ-D) and digit symbol substitution test (DSST), respectively. Depressive symptoms, as well as remission and early response to treatment, were assessed using the Montgomery-Asberg Depression Rating Scale (MADRS). Multivariable linear and logistic regression models were used to adjust for confounders. Early response of depressive mood (≥50% reduction in MADRS score at month 1) was related with fewer residual subjective cognitive symptoms, as evaluated by the PDQ-D at month 6 (p
ISSN:0165-0327
1573-2517
DOI:10.1016/j.jad.2021.09.025